2024-02-13 07:21:19 ET
Summary
- Givaudan reported solid 2023 results, with total sales declining 2.8% but showing healthy growth on a like-for-like basis.
- The Fragrance & Beauty segment performed well, while the Taste & Well-being segment was weaker.
- Givaudan operates in an attractive industry with strong competitive advantages, but the stock is considered overvalued.
A little over a year ago, we started covering Givaudan (GVDBF)(GVDNY), highlighting its strong competitive moat and the attractive characteristics of its business model and industry. We gave it a 'Hold' rating given that we saw it as slightly overvalued. However, that didn't stop the shares from outperforming the market, delivering a return of over 37% since then, compared to roughly 26% for the S&P 500 index ( SPY )....
Read the full article on Seeking Alpha
For further details see:
Givaudan: Exceptional Yet It Remains Priced Beyond Reach